Brief: Nordic Nanovector: New Preclinical Data Offer Insights Into Enhancing Betalutin-Based Therapies In NHL

Thor Medical ASA

04/12/2019 06:16

Dec 4 (Reuters) - Nordic Nanovector ASA  NANOV.OL :
    * NORDIC NANOVECTOR: NEW PRECLINICAL DATA OFFER INSIGHTS
INTO
ENHANCING
    * NEW DATA FROM PRECLINICAL STUDIES INVESTIGATING EFFECT OF
BETALUTIN ON NON-HODGKIN'S LYMPHOMA CELL LINES WILL BE PRESENTED
IN A POSTER AT 61 AMERICAN SOCIETY OF HEMATOLOGY ANNUAL MEETING
& EXPOSITION

Source text for Eikon:  ID:nObiqJYRVa 
Further company coverage:  NANOV.OL 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))